BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22949266)

  • 21. Recent thymic origin, differentiation, and turnover of regulatory T cells.
    Mabarrack NH; Turner NL; Mayrhofer G
    J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyclonal expansion of human CD4(+)CD25(+) regulatory T cells.
    Hoffmann P; Eder R; Edinger M
    Methods Mol Biol; 2011; 677():15-30. PubMed ID: 20941600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
    Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
    Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
    Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
    Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
    Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM
    J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells.
    Mesquita D; de Melo Cruvinel W; Araujo J; Pucci F; Salmazi K; Kallas E; Andrade L
    Scand J Rheumatol; 2011 Jan; 40(1):41-50. PubMed ID: 20936986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
    Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
    J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
    Taylor AL; Llewelyn MJ
    J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells.
    Nagar M; Vernitsky H; Cohen Y; Dominissini D; Berkun Y; Rechavi G; Amariglio N; Goldstein I
    Int Immunol; 2008 Aug; 20(8):1041-55. PubMed ID: 18567616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of CD4+CD25 high Foxp3+ T cells in ovine peripheral blood.
    Rocchi MS; Wattegedera SR; Frew D; Entrican G; Huntley JF; McNeilly TN
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):172-7. PubMed ID: 21831456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
    Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
    Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
    Chen X; Zhou B; Li M; Deng Q; Wu X; Le X; Wu C; Larmonier N; Zhang W; Zhang H; Wang H; Katsanis E
    Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression patterns of HLA-DR+ or HLA-DR- on CD4+/CD25++/CD127low regulatory T cells in patients with allergy.
    Geraldes L; Morgado J; Almeida A; Todo-Bom A; Santos P; Paiva A; Cheira C; Pais ML
    J Investig Allergol Clin Immunol; 2010; 20(3):201-9. PubMed ID: 20635785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells.
    Carter CR; Aravind G; Smalle NL; Cole JY; Savic S; Wood PM
    J Clin Pathol; 2013 Feb; 66(2):146-50. PubMed ID: 23172556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
    Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
    Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.